Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Clinical Site, Milan

Clinical Site, Milan

Clinical Site, Seville

Clinical Site, Seville

Clinical Site, Seville

Clinical Site, Paris

Clinical Site, Paris

Clinical Site, Paris

Clinical Site, Moscow

Clinical site, Moscow

Clinical site, Moscow

Clinical site, Saratov

Clinical Site, Saratov

Clinical Site, Leuven

Clinical Site, Liège

Clinical Site, Hradec Králové

Clinical Site, Angers

Clinical Site, Brest

Clinical Site, Créteil

Clinical Site, Grenoble

Clinical Site, Lille

Clinical Site, Montpellier

Clinical Site, Pessac

Clinical Site, Poitiers

Clinical Site, Jena

Clinical Site, Aachen

Clinical Site, Berlin

Clinical Site, Cologne

Clinical Site, Dresden

Clinical Site, Essen

Clinical Site, Freiburg im Breisgau

Clinical Site, Hanover

Clinical Site, Kirchheim unter Teck

Clinical Site, Leipzig

Clinical Site, Ludwigshafen

Clinical Site, Mannheim

Clinical Site, Münster

Clinical Site, Stuttgart

Clinical Site, Catania

Clinical Site, Lecco

Clinical Site, Messina

Clinical Site, Monza

Clinical Site, Pavia

Clinical Site, Pisa

Clinical Site, Verona

Clinical Site, Maastricht

Clinical Site, Rotterdam

Clinical Site, Kemerovo

Clinical Site, Orenburg

Clinical Site, Petrozavodsk

Clinical Site, Yaroslavl

Clinical Site, Alcorcón

Clinical Site, Badalona

Clinical Site, Barcelona

Clinical Site, Fuenlabrada

Clinical Site, L'Hospitalet de Llobregat

Clinical Site, Gothenburg

Clinical Site, Stockholm

Clinical Site, Uppsala

Clinical Site, Sankt Gallen

Clinical Site, Zurich

Clinical Site, Aberdeen

Clinical Site, Cambridge

Clinical Site, Cardiff

Clinical Site, Leicester

Clinical Site, Portsmouth

Clinical Site, Preston

Clinical Site, Reading

Clinical Site, Sheffield

Clinical Site, Prague

Clinical Site, Prague

Clinical Site, Prague

Clinical Site, Barcelona

Clinical site, Barcelona

Clinical Site, London

Clinical Site, London